• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染基孔肯雅病毒后小鼠大脑中 TLR3 介导的固有免疫反应。

TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus.

机构信息

Division of Virology, Defence Research & Development Establishment, Gwalior 474002, India.

School of Studies in Neurosciences, Jiwaji University, Gwalior 474002, India.

出版信息

Virus Res. 2014 Aug 30;189:194-205. doi: 10.1016/j.virusres.2014.05.010. Epub 2014 Jun 4.

DOI:10.1016/j.virusres.2014.05.010
PMID:24905288
Abstract

Chikungunya virus (CHIKV) has received global attention due to the series of large-scale outbreaks in different parts of the world. Many unusual clinical severities including neurological complications and death were reported in recent outbreaks. The mechanism underlying the host immune response to CHIKV in the brain is poorly characterized. In this study, the neuropathogenesis of CHIKV with E1:A226V mutation was elucidated in 1 week old BALB/c mice. The virus was found to replicate in mice brain with peak titer of 10(4) on 6th day post infection. Immunohistochemical analysis revealed preferential virus localization in neuronal cells of cerebellum. The expression profiling of TLR, antiviral genes and cytokines in mice brain revealed significant up regulation of TLR3, TRAF-6, TICAM-1, MCP-1, CXCL-10, IL-6, IL-4, ISG-15, MX-2, IFN-β, OAS-3 genes that ultimately resulted in virus clearance from brain by day 9-10 suggesting activation of innate immune pathway. Further the effect of poly I: C (Polyinosinic: Polycytidylic acid), a TLR-3 agonist and potent IFN inducer on CHIKV neuropathogenesis was studied. Pretreatment of mice with Poly I: C caused reduction of CHIKV titer in brain and offered 100% protection of animals. The protection was mediated by an increased induction of TLR3, IFN-β and antiviral genes in mice brain. Our result demonstrates that pre immune stimulation of animals by Poly I: C is effective inhibitor of CHIKV replication and might be a promising prevention agent against this virus.

摘要

基孔肯雅病毒(CHIKV)在世界不同地区爆发了一系列大规模疫情,因此受到了全球关注。最近的疫情报告了许多不寻常的临床严重程度,包括神经并发症和死亡。宿主对 CHIKV 在大脑中的免疫反应的机制尚未得到很好的描述。在这项研究中,阐明了具有 E1:A226V 突变的 CHIKV 在 1 周龄 BALB/c 小鼠中的神经发病机制。该病毒在感染后第 6 天在小鼠脑中复制,滴度峰值为 10(4)。免疫组织化学分析显示病毒优先定位于小脑神经元细胞中。对小鼠大脑中 TLR、抗病毒基因和细胞因子的表达谱分析显示,TLR3、TRAF-6、TICAM-1、MCP-1、CXCL-10、IL-6、IL-4、ISG-15、MX-2、IFN-β、OAS-3 基因的表达显著上调,这些基因最终导致病毒在第 9-10 天从大脑中清除,提示先天免疫途径的激活。进一步研究了 TLR-3 激动剂和强效 IFN 诱导剂 Poly I:C(聚肌苷酸:聚胞苷酸)对 CHIKV 神经发病机制的影响。用 Poly I:C 预处理小鼠可降低脑中的 CHIKV 滴度,并为 100%的动物提供保护。这种保护是通过增加小鼠大脑中 TLR3、IFN-β 和抗病毒基因的诱导来介导的。我们的结果表明,用 Poly I:C 对动物进行免疫前刺激是 CHIKV 复制的有效抑制剂,可能是预防这种病毒的有前途的药物。

相似文献

1
TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus.感染基孔肯雅病毒后小鼠大脑中 TLR3 介导的固有免疫反应。
Virus Res. 2014 Aug 30;189:194-205. doi: 10.1016/j.virusres.2014.05.010. Epub 2014 Jun 4.
2
Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation.新型 ECSA 基因型基孔肯雅病毒感染小鼠神经元细胞后 TLR 介导的固有免疫反应的差异调节,以及 E1:A226V 突变的有无。
Infect Genet Evol. 2013 Dec;20:396-406. doi: 10.1016/j.meegid.2013.09.030. Epub 2013 Oct 12.
3
Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells.多聚肌苷酸:胞苷酸,一种 Toll 样受体 3 的激动剂,可抑制 BEAS-2B 细胞中基孔肯雅病毒的复制。
Virol J. 2012 Jun 14;9:114. doi: 10.1186/1743-422X-9-114.
4
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.由于病毒特异性中和抗体反应改变,Toll样受体3(TLR3)的缺失会加重基孔肯雅病毒(CHIKV)的复制和病理变化。
EMBO Mol Med. 2015 Jan;7(1):24-41. doi: 10.15252/emmm.201404459.
5
Interferon regulated gene (IRG) expression-signature in a mouse model of chikungunya virus neurovirulence.干扰素调节基因(IRG)表达谱在基孔肯雅病毒神经毒力的小鼠模型中。
J Neurovirol. 2017 Dec;23(6):886-902. doi: 10.1007/s13365-017-0583-3. Epub 2017 Oct 24.
6
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.干扰素 α 和 β 在控制基孔肯雅病毒复制和调节中性粒细胞介导的炎症中的独特作用。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.00841-19.
7
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.加勒比地区和留尼汪岛的基孔肯雅病毒分离株在诱导促炎性Th1和NK细胞反应以及急性关节病变的能力上存在差异。
J Virol. 2015 Aug;89(15):7955-69. doi: 10.1128/JVI.00909-15. Epub 2015 May 20.
8
Interleukin 27 as an inducer of antiviral response against chikungunya virus infection in human macrophages.白细胞介素 27 作为一种诱导抗病毒反应的因子,可抵抗人巨噬细胞感染基孔肯雅病毒。
Cell Immunol. 2021 Sep;367:104411. doi: 10.1016/j.cellimm.2021.104411. Epub 2021 Jul 21.
9
Chikungunya virus pathogenesis and immunity.基孔肯雅病毒的发病机制与免疫
Vector Borne Zoonotic Dis. 2015 Apr;15(4):241-9. doi: 10.1089/vbz.2014.1710.
10
Cellular and molecular mechanisms of chikungunya pathogenesis.基孔肯雅热发病机制的细胞和分子机制。
Antiviral Res. 2015 Aug;120:165-74. doi: 10.1016/j.antiviral.2015.06.009. Epub 2015 Jun 16.

引用本文的文献

1
Toll-like Receptor (TLR) Response in Chikungunya Virus Infection: Mechanism of Activation, Immune Evasion, and Use of TLR Agonists in Vaccine Development.基孔肯雅病毒感染中的Toll样受体(TLR)反应:激活机制、免疫逃逸以及TLR激动剂在疫苗开发中的应用
Vaccines (Basel). 2025 Aug 13;13(8):856. doi: 10.3390/vaccines13080856.
2
X-linked polymorphisms in TLR7 and TLR8 genes are associated with protection against Chikungunya fever.Toll样受体7(TLR7)和Toll样受体8(TLR8)基因中的X连锁多态性与抵御基孔肯雅热有关。
Mem Inst Oswaldo Cruz. 2025 Jun 13;120:e230224. doi: 10.1590/0074-02760230224. eCollection 2025.
3
Interferon-induced protein ISG15 in the central nervous system, quo vadis?
中枢神经系统中干扰素诱导蛋白ISG15,何去何从?
FEBS Lett. 2025 May 12. doi: 10.1002/1873-3468.70063.
4
Eastern equine encephalitis virus: Pathogenesis, immune response, and clinical manifestations.东部马脑炎病毒:发病机制、免疫反应及临床表现
Infect Med (Beijing). 2025 Jan 17;4(1):100167. doi: 10.1016/j.imj.2025.100167. eCollection 2025 Mar.
5
Neuropathogenesis of Old World Alphaviruses: Considerations for the Development of Medical Countermeasures.旧大陆甲病毒的神经发病机制:医学应对措施研发的考量因素
Viruses. 2025 Feb 14;17(2):261. doi: 10.3390/v17020261.
6
Toll-like receptor 3: a double-edged sword.Toll样受体3:一把双刃剑。
Biomark Res. 2025 Feb 23;13(1):32. doi: 10.1186/s40364-025-00739-5.
7
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches.针对蚊媒病毒的抗病毒策略进展:细胞、病毒及免疫相关方法
Virol J. 2025 Feb 4;22(1):26. doi: 10.1186/s12985-025-02622-z.
8
Unraveling the complex interplay: immunopathology and immune evasion strategies of alphaviruses with emphasis on neurological implications.解析复杂性相互作用:重视神经影响的甲病毒的免疫病理学和免疫逃逸策略。
Front Cell Infect Microbiol. 2024 Aug 15;14:1421571. doi: 10.3389/fcimb.2024.1421571. eCollection 2024.
9
Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions.基孔肯雅病毒疫苗:解决流行病学困境、新出现概念及免疫干预措施的十年进展
Front Microbiol. 2024 Jul 22;15:1413250. doi: 10.3389/fmicb.2024.1413250. eCollection 2024.
10
Attenuation of neurovirulence of chikungunya virus by a single amino acid mutation in viral E2 envelope protein.通过病毒 E2 包膜蛋白中的单个氨基酸突变来减弱基孔肯雅病毒的神经毒力。
J Biomed Sci. 2024 Jan 17;31(1):8. doi: 10.1186/s12929-024-00995-x.